Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT04168099

PHASE3

Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis

Official title: Comparative Study Between the Efficacy of Oral Gemifloxacin and Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

Start Date

2018-12-01

Completion Date

2028-12-30

Last Updated

2019-11-19

Healthy Volunteers

Conditions

Spontaneous Bacterial Peritonitis

Interventions

DRUG

Cefotaxime

Cefotaxime IV

DRUG

Gemifloxacin

Gemifloxacin oral

Locations (1)

Sherief Abd-Elsalam

Tanta, Egypt